- Home
- CDIO
as 05-20-2024 2:31pm EST
Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | CHICAGO |
| Market Cap: | 19.3M | IPO Year: | N/A |
| Target Price: | $4.68 | AVG Volume (30 days): | 602.6K |
| Analyst Decision: | Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.75 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.17 - $3.56 | Next Earning Date: | 05-28-2024 |
| Revenue: | $32,993 | Revenue Growth: | 3372.95% |
| Revenue Growth (this year): | 16858.69% | Revenue Growth (next year): | 305.32% |
Share on Social Networks:
Latest Cardio Diagnostics Holdings Inc. Common stock News
CDIO Breaking Stock News: Dive into CDIO Ticker-Specific Updates for Smart Investing
Business Wire
7 days ago
Cardio Diagnostics Holdings, Inc. Announces the Availability of Its Clinical Tests at Family Medicine Specialists’ Retail Healthcare Clinic at Walmart Supercenter in Round Lake Beach, Illinois, That Offers Walk-In Appointments Seven Days a Week
Business Wire
21 days ago
Cardio Diagnostics Announces Publication of Study Showing That its PrecisionCHD™ Test Could Save Health Insurers Over $113 Million Annually
Business Wire
a month ago
Exponential Health Partners with Cardio Diagnostics to Elevate Cardiovascular Disease Prevention in Michigan
Business Wire
2 months ago
Cardio Diagnostics Holdings, Inc. Enters Into a Nationwide Telehealth Agreement with Navierre
Simply Wall St.
2 months ago
Cardio Diagnostics Holdings Full Year 2023 Earnings: EPS Beats Expectations, Revenues Lag
Business Wire
2 months ago
Cardio Diagnostics Holdings, Inc. to Showcase HeartRisk and Actionable Clinical Intelligence Version 3 at the American College of Cardiology’s 73rd Annual Scientific Session
Business Wire
3 months ago
Cardio Diagnostics Holdings, Inc. Announces Issuance of Second U.S. Patent for Compositions and Methods for Detecting Predisposition to Cardiovascular Disease
Business Wire
3 months ago